Oxford BioDynamics (LON:OBD) Sets New 12-Month Low – Should You Sell?

Oxford BioDynamics Plc (LON:OBD)’s share price reached a new 52-week low on Monday . The stock traded as low as GBX 0.45 ($0.01) and last traded at GBX 0.47 ($0.01), with a volume of 32203789 shares changing hands. The stock had previously closed at GBX 0.47 ($0.01).

Oxford BioDynamics Price Performance

The company’s 50-day simple moving average is GBX 0.90 and its 200-day simple moving average is GBX 2.61. The company has a debt-to-equity ratio of 370.22, a current ratio of 0.68 and a quick ratio of 2.80. The stock has a market capitalization of £8.90 million, a price-to-earnings ratio of -0.08 and a beta of 0.42.

About Oxford BioDynamics

Oxford BioDynamics Plc is a global biotechnology company, advancing personalized healthcare by developing and commercializing precision medicine tests for life-changing diseases.

Its flagship product is EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) for cancer, a predictive immune response profile for immuno-oncology (IO) checkpoint inhibitor treatments, launched in February 2022.

In March 2021, the Company launched its first commercial prognostic test, EpiSwitch® CST (Covid Severity Test) and the first commercially available microarray kit for high-resolution 3D genome profiling and biomarker discovery, EpiSwitch® Explorer Array Kit.